# FDA Inspection 1231316 - Peyman Saadat MD, Inc. - February 20, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/peyman-saadat-md-inc/e226d855-6e16-4b64-9d28-5ef11a67542a/
Source feed: FDA_Inspections

> FDA Inspection 1231316 for Peyman Saadat MD, Inc. on February 20, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231316
- Company Name: Peyman Saadat MD, Inc.
- Inspection Date: 2024-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1231316 - 2024-02-20](https://www.globalkeysolutions.net/api/records/fda_inspections/peyman-saadat-md-inc/ce1a4e03-9f1a-4a23-aa8c-8fb11e9c233a/)
- [FDA Inspection 1045088 - 2018-03-21](https://www.globalkeysolutions.net/api/records/fda_inspections/peyman-saadat-md-inc/f1ec9f87-5e0b-4d1e-83f0-49baae854f90/)
- [FDA Inspection 1045088 - 2018-03-21](https://www.globalkeysolutions.net/api/records/fda_inspections/peyman-saadat-md-inc/9f858728-d281-41fb-9e6c-a5a7a92a42d5/)
- [FDA Inspection 938669 - 2015-07-29](https://www.globalkeysolutions.net/api/records/fda_inspections/peyman-saadat-md-inc/f15ecd55-f198-41c7-b2d8-2b577ca1c8af/)
- [FDA Inspection 796642 - 2012-08-16](https://www.globalkeysolutions.net/api/records/fda_inspections/peyman-saadat-md-inc/3b37425b-4302-4259-860b-69651a8a1de5/)

Company: https://www.globalkeysolutions.net/companies/peyman-saadat-md-inc/2128187d-8aeb-4e88-ad5f-ae65b674bae7

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d